← All companies
ARTIVION, INC.
AORT - CIK 0000784199
Market cap$995.14 M
Rank#2640
SEC filings2,371
ARTIVION, INC. trades as AORT and has a market capitalization of $995.14 M, making it the #2640 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $441.33M, up 13.6% from the prior year and net income of $9.77M. This page tracks ARTIVION, INC. through 2,371 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$441.33MFY 2025
Net income (latest FY)$9.77MFY 2025
Operating cash flow (latest FY)$39.88MFY 2025
Total assets (latest FY)$884.80MFY 2025
Gross margin64.4%latest FY
Net margin2.2%latest FY
Financial performance
Over the last 9 fiscal years ARTIVION, INC.'s revenue grew from $180.38M to $441.33M, a compound annual growth rate of 10.5%. Net profit margin compressed from 6.0% to 2.2% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $995.14 M
- Share price (derived)market cap / shares outstanding
- $20.50
- P/E ratio (trailing FY)
- 101.9
- EPS (diluted)FY 2025
- $0.21
- Shares outstandingas of 2026-05-01
- 0.05B
- Total equityas of 2026-03-31
- $450.47M
- Return on equity
- 2.2%
- Long-term debtas of 2026-03-31
- $215.35M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| SD | - | 2026-05-21 |
| Insider trade (amended) | 4/A | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
Recent press releases
- Artivion Completes Acquisition of Endospan Ltd.2026-05-18
Artivion Completes Acquisition of Endospan Ltd. | Artivion, Inc.
- Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan2026-05-07
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan | Artivion, Inc.
- Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results2026-04-23
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results | Artivion, Inc.
- Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System2026-04-07
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System | Artivion, Inc.
- Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference2026-03-03
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference | Artivion, Inc.
Similar companies
The largest companies sharing ARTIVION, INC.'s SEC industry classification (surgical & medical instruments & apparatus).
Frequently asked questions
What is ARTIVION, INC.'s market cap?
ARTIVION, INC. (AORT) has a market capitalization of $995.14 M as of 2026-06-10, ranking #2640 among US-listed companies.
How much revenue does ARTIVION, INC. make?
ARTIVION, INC. reported revenue of $441.33M for fiscal year 2025, an increase of 13.6% year over year.
Is ARTIVION, INC. profitable?
Yes. ARTIVION, INC. reported net income of $9.77M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.